BAMBOOSHEALTH (02293) Announces Annual Results, Profit for the Year at HK$6.235 Million, Down 64.45% Year-on-Year
Bamboos Health (02293) announced its annual results for the year ended 30 June 2026. The Group recorded total revenue of HK$66.5 million, down 10.6% year-on-year; profit for the year was HK$6.235 million, down 64.45% year-on-year; basic earnings per share were 1.56 HK cents; final dividend was 2.5 HK cents per share.
BAMBOOSHEALTH (02293) announced its annual results for the year ended 30 June 2026. The group recorded total revenue of HK$66.5 million, down 10.6% year-on-year; profit for the year of HK$6.235 million, down 64.45% year-on-year; basic earnings per share of 1.56 HK cents; and a final dividend of 2.5 HK cents per share.
Related Articles
US Stock Market Move | Royal Caribbean Cruises (RCL.US) Falls 3% on Plan to Acquire Half of Sandals for $3 Billion
Meta (META.US) Wins More Wall Street Bullish Calls After Muse Goes Viral! Cantor Fitzgerald Raises Price Target to $860, Trillion-Dollar AI Agent Market in Sight
CENTRALCHINA MT (09982) plans to acquire a 25% stake in Lianheng Technology for HK$100 million, launching a "construction management + AI technology" business model.
US Stock Market Move | Royal Caribbean Cruises (RCL.US) Falls 3% on Plan to Acquire Half of Sandals for $3 Billion
Meta (META.US) Wins More Wall Street Bullish Calls After Muse Goes Viral! Cantor Fitzgerald Raises Price Target to $860, Trillion-Dollar AI Agent Market in Sight
CENTRALCHINA MT (09982) plans to acquire a 25% stake in Lianheng Technology for HK$100 million, launching a "construction management + AI technology" business model.
